JPRN-jRCT2031230194尚未招募Unknown
Post-marketing database survey: A cohort study of comparison the risk of haemorrhage (serious intracranial haemorrhage such as cerebral haemorrhage and subarachnoid haemorrhage) between Vortioxetine Tablets and SSRIs in patients with depression using JMDC claims database
Contact for Clinical Trial Information0 个研究点目标入组 115,000 人开始时间: 2023年7月1日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
- 入组人数
- 115,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- •1.Has diagnosis of depression and prescription of Vortioxetine tablet or SSRI within the enrollment period (Index Date: first prescription date within the enrollment period).
- •2.Participants can be observed for the past 6 months (180 days) (Look back period) from the day before the Index Date.
- •3.Had not prescription of Vortioxetine tablet or SSRI in the Look back period.
排除标准
- •1.Has diagnosis of intracranial hemorrhage during the look back period.
- •2.Has been taken Vortioxetine tablet in combination with SSRI on the index date.
研究者
相似试验
已完成
不适用
A non-interventional, post-marketing survey study of healthcare professionals based on their experience using a high-fiber enteral feeding.ConstipationJPRN-UMIN000048410estle Health Science Company, Nestle Japan Ltd.184
尚未招募
Unknown
Observational, Postmarketing Study to Evaluate the Safety of AmBisome®CTRI/2023/08/057070Gilead Sciences Inc
已完成
4 期
Post-marketing SurveillanceStudy in patients prescribed with Darbepoetin alfaCTRI/2017/04/008338Hetero Drugs Limited503
尚未招募
4 期
Post marketing surveillance study of Pitavastatin for evaluation of its safety and efficacy in patients with diabetes and high cholesterolCTRI/2013/05/003686Cadila Healthcare500
已完成
4 期
A study of Pregabalin IP 75 mg and Nortriptyline 10 mg Tablets in patients with diabetic peripheral neuropathyCTRI/2022/02/040438Micro Labs Limited203